NOTE: This video is ONLY available to watch in selected countries and geographies
Edgar Samaniego (University of Iowa, Iowa City, USA) discusses his experiences to date with one of the latest technologies in the mechanical thrombectomy space—the CEREGLIDE™ 71 Intermediate Catheter with TruCourse™ technology (Cerenovus/Johnson & Johnson). In this video interview, Samaniego urges his neurointerventional peers to try the device out in the near future, citing trackability and tip durability as being among its salient characteristics.
The benefits described by Edgar Samaniego are based on his clinical experience. Samaniego is compensated by and presenting on behalf of Johnson & Johnson, and must present information in accordance with applicable regulatory requirements.
This video is sponsored by Cerenovus, part of Johnson & Johnson MedTech.
© CERENOVUS 2024 US_CNV_ISCH_344521
